Shire (SHPGF US)

Shire was a global specialty biopharmaceutical company that focused on developing and marketing medicines for rare diseases and other highly specialized conditions. Its products spanned therapeutic areas including hematology, immunology, neuroscience, gastrointestinal conditions, and ophthalmology. Shire was founded in 1986 and acquired by Takeda Pharmaceutical Company in 2019.